Cargando…

Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy

Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old...

Descripción completa

Detalles Bibliográficos
Autores principales: Doguizi, Sibel, Sekeroglu, Mehmet Ali, Anayol, Mustafa Alpaslan, Yilmazbas, Pelin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684840/
https://www.ncbi.nlm.nih.gov/pubmed/26770854
http://dx.doi.org/10.1155/2015/137270
_version_ 1782406215498727424
author Doguizi, Sibel
Sekeroglu, Mehmet Ali
Anayol, Mustafa Alpaslan
Yilmazbas, Pelin
author_facet Doguizi, Sibel
Sekeroglu, Mehmet Ali
Anayol, Mustafa Alpaslan
Yilmazbas, Pelin
author_sort Doguizi, Sibel
collection PubMed
description Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old boy presented with a complaint of low visual acuity (best corrected visual acuity: 20/80 in both eyes, refractive error: −12.00 D). Dilated fundus examination revealed multiple bilateral, sharply defined, and scalloped chorioretinal atrophy areas in the midperipheral and peripheral zone. Spectral-domain optical coherence tomography revealed bilateral cystoid macular edema in both eyes. Serum ornithine level was high (622 μmol/L). An arginine-restricted diet reduced serum ornithine level (55 μmol/L). However, visual findings including macular edema remained unchanged in 2 years of follow-up. Conclusion. Arginine-restricted diet did not improve macular edema in our patient with gyrate atrophy. A more comprehensive understanding of the underlying factors for macular edema will lead to the development of effective therapies.
format Online
Article
Text
id pubmed-4684840
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Hindawi Publishing Corporation
record_format MEDLINE/PubMed
spelling pubmed-46848402016-01-14 Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy Doguizi, Sibel Sekeroglu, Mehmet Ali Anayol, Mustafa Alpaslan Yilmazbas, Pelin Case Rep Ophthalmol Med Case Report Introduction. Gyrate atrophy is a rare genetical metabolic disorder affecting vision. Here, we report a 9-year-old boy with gyrate atrophy associated with bilateral macular edema at the time of diagnosis and the effect of long term metabolic control on macular edema. Case Presentation. A 9-year-old boy presented with a complaint of low visual acuity (best corrected visual acuity: 20/80 in both eyes, refractive error: −12.00 D). Dilated fundus examination revealed multiple bilateral, sharply defined, and scalloped chorioretinal atrophy areas in the midperipheral and peripheral zone. Spectral-domain optical coherence tomography revealed bilateral cystoid macular edema in both eyes. Serum ornithine level was high (622 μmol/L). An arginine-restricted diet reduced serum ornithine level (55 μmol/L). However, visual findings including macular edema remained unchanged in 2 years of follow-up. Conclusion. Arginine-restricted diet did not improve macular edema in our patient with gyrate atrophy. A more comprehensive understanding of the underlying factors for macular edema will lead to the development of effective therapies. Hindawi Publishing Corporation 2015 2015-12-06 /pmc/articles/PMC4684840/ /pubmed/26770854 http://dx.doi.org/10.1155/2015/137270 Text en Copyright © 2015 Sibel Doguizi et al. https://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Doguizi, Sibel
Sekeroglu, Mehmet Ali
Anayol, Mustafa Alpaslan
Yilmazbas, Pelin
Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title_full Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title_fullStr Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title_full_unstemmed Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title_short Arginine-Restricted Therapy Resistant Bilateral Macular Edema Associated with Gyrate Atrophy
title_sort arginine-restricted therapy resistant bilateral macular edema associated with gyrate atrophy
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684840/
https://www.ncbi.nlm.nih.gov/pubmed/26770854
http://dx.doi.org/10.1155/2015/137270
work_keys_str_mv AT doguizisibel argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy
AT sekeroglumehmetali argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy
AT anayolmustafaalpaslan argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy
AT yilmazbaspelin argininerestrictedtherapyresistantbilateralmacularedemaassociatedwithgyrateatrophy